Taruna Ahrodia, Bharti Kandiyal & Bhabatosh Das. 2023. Epigenetics in Health and Disease - Part B. Epigenetics in Health and Disease - Part B
93
117
.
Kelly R. Reveles, Eric H. Young, Amina R.A.L. Zeidan & Qunfeng Dong. 2021. Handbook of the Biology of Aging. Handbook of the Biology of Aging
367
389
.
Maurício Roberto Motta Pinto da Luz & Ricardo Francisco Waizbort. (2020) Transplantes de microbiota fecal para tratamento da colite pseudomembranosa (1958-2013): prioridade de descoberta e estilos de pensamento na literatura acadêmica. História, Ciências, Saúde-Manguinhos 27:3, pages 859-878.
Crossref
Hao-Yuan Lee, Hsuan-Ling Hsiao, Chin-Yuan Chia, Chun-Wen Cheng, Tzu-Cheng Tsai, Shin-Tarng Deng, Chyi-Liang Chen & Cheng-Hsun Chiu. (2019) Risk factors and outcomes of Clostridium difficile infection in hospitalized patients. Biomedical Journal 42:2, pages 99-106.
Crossref
Brooke C. Wilson, Tommi Vatanen, Wayne S. Cutfield & Justin M. O'Sullivan. (2019) The Super-Donor Phenomenon in Fecal Microbiota Transplantation. Frontiers in Cellular and Infection Microbiology 9.
Crossref
Emily C. Woods, Adrianne N. Edwards, Kevin O. Childress, Joshua B. Jones & Shonna M. McBride. (2018) The C. difficile clnRAB operon initiates adaptations to the host environment in response to LL-37. PLOS Pathogens 14:8, pages e1007153.
Crossref
L. Chris Sanchez. 2018. Equine Internal Medicine. Equine Internal Medicine
709
842
.
K Al-Tawil, A Babu, M Loeffler & T Williams. (2017)
Second generation cephalosporin antibiotic prophylaxis and
Clostridium difficile
infection in hip and knee arthroplasty
. The Annals of The Royal College of Surgeons of England 99:5, pages 351-354.
Crossref
Mark H. Wilcox, James D. Chalmers, Carl E. Nord, Jane Freeman & Emilio Bouza. (2017)
Role of cephalosporins in the era of
Clostridium difficile
infection
. Journal of Antimicrobial Chemotherapy 72:1, pages 1-18.
Crossref
C. Rodriguez, B. Taminiau, J. Van Broeck, M. Delmée & G. Daube. (2015) Clostridium difficile infection and intestinal microbiota interactions. Microbial Pathogenesis 89, pages 201-209.
Crossref
Joy Scaria, Jenn-Wei Chen, Nicodemus Useh, Hongxuan He, Sean P. McDonough, Chunhong Mao, Bruno Sobral & Yung-Fu Chang. (2014) Comparative nutritional and chemical phenome of Clostridium difficile isolates determined using phenotype microarrays. International Journal of Infectious Diseases 27, pages 20-25.
Crossref
. 2014. Interactive Probiotics. Interactive Probiotics
30
59
.
Eva Boon, Conor J. Meehan, Chris Whidden, Dennis H.-J. Wong, Morgan G.I. Langille & Robert G. Beiko. (2014) Interactions in the microbiome: communities of organisms and communities of genes. FEMS Microbiology Reviews 38:1, pages 90-118.
Crossref
Fleur Ponton, Kenneth Wilson, Andrew J. Holmes, Sheena C. Cotter, David Raubenheimer & Stephen J. Simpson. (2013) Integrating nutrition and immunology: A new frontier. Journal of Insect Physiology 59:2, pages 130-137.
Crossref
Jesse Clanton. (2013)
Fulminant
Clostridium difficile
infection: An association with prior appendectomy?
. World Journal of Gastrointestinal Surgery 5:8, pages 233.
Crossref
Marc Liggins, Norma Ramirez, Natiera Magnuson & Ernesto Abel-Santos. (2011) Progesterone Analogs Influence Germination of Clostridium sordellii and Clostridium difficile Spores In Vitro. Journal of Bacteriology 193:11, pages 2776-2783.
Crossref
Charles Spielholz. (2011) Efficacy of a synbiotic chewable tablet in the prevention of antibiotic-associated diarrhea. Health 03:02, pages 110-115.
Crossref
Cirle A Warren & Richard L Guerrant. (2011) Pathogenic C difficile is here (and everywhere) to stay. The Lancet 377:9759, pages 8-9.
Crossref
Norma Ramirez, Marc Liggins & Ernesto Abel-Santos. (2010)
Kinetic Evidence for the Presence of Putative Germination Receptors in
C
lostridium difficile
Spores
. Journal of Bacteriology 192:16, pages 4215-4222.
Crossref
Mohammad Azam & Richard J. Farrell. 2010. Inflammatory Bowel Disease. Inflammatory Bowel Disease
619
642
.
Gareth C Parkes, Jeremy D Sanderson & Kevin Whelan. (2009) The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. The Lancet Infectious Diseases 9:4, pages 237-244.
Crossref
Douglas S. Swanson. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Feigin and Cherry's Textbook of Pediatric Infectious Diseases
110
117
.
Dimitrios Vassos, Vassiliki Maipa, Chrysa Voidarou, Athanasios Alexopoulos & Eugenia Bezirtzoglou. (2008) Development of human lactic acid (LAB) gastrointestinal microbiota in a Greek rural population. Open Life Sciences 3:1, pages 55-60.
Crossref
B. Razavi, A. Apisarnthanarak & L. M. Mundy. (2007) Clostridium difficile: Emergence of Hypervirulence and Fluoroquinolone Resistance. Infection 35:5, pages 300-307.
Crossref
Farrin A. Manian, Sangita Aradhyula, Sandy Greisnauer, Diane Senkel, Janice Setzer, Michele Wiechens & P Lynn Meyer. (2007) Is It Clostridium difficile Infection or Something Else? A Case-control Study of 352 Hospitalized Patients With New-onset Diarrhea. Southern Medical Journal 100:8, pages 782-786.
Crossref
Michael J. YaegerJoann M. KinyonJ. Glenn Songer. (2016)
A Prospective, Case Control Study Evaluating the Association between
Clostridium Difficile
Toxins in the Colon of Neonatal Swine and Gross and Microscopic Lesions
. Journal of Veterinary Diagnostic Investigation 19:1, pages 52-59.
Crossref
J. Hughes, N. Taylor, E. Cerda & M.A. de la Cal. 2005. Infection Control in the Intensive Care Unit. Infection Control in the Intensive Care Unit
191
211
.
S. Buyse, E. Azoulay & B. Schlemmer. 2005. Yearbook of Intensive Care and Emergency Medicine 2005. Yearbook of Intensive Care and Emergency Medicine 2005
369
381
.
Richard J. Farrell, Lorraine Kyne & Ciarán P. Kelly. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
823
844
.
Reet Mandar, Marika Mikelsaar, Epp Sepp & Heidi Annuk. 2004. Lactic Acid Bacteria. Lactic Acid Bacteria.
Thomas J Borody, Eloise F Warren, Sharyn M Leis, Rosa Surace, Ori Ashman & Steven Siarakas. (2004) Bacteriotherapy Using Fecal Flora. Journal of Clinical Gastroenterology 38:6, pages 475-483.
Crossref
John R. Stroehlein. (2004) Treatment of clostridium difficile infection. Current Treatment Options in Gastroenterology 7:3, pages 235-239.
Crossref
Eijiro Ozaki, Haru Kato, Hiroyuki Kita, Tadahiro Karasawa, Tsuneo Maegawa, Youko Koino, Kazumasa Matsumoto, Toshihiko Takada, Koji Nomoto, Ryuichiro Tanaka & Shinichi Nakamura. (2004) Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization. Journal of Medical Microbiology 53:2, pages 167-172.
Crossref
Paul Naaber & Marika Mikelsaar. 2004.
231
260
.
Samuel L. Jones & Anthony T. Blikslager. 2004. Equine Internal Medicine. Equine Internal Medicine
769
949
.
Carl-Gustaf Nettelbladt, Mohammad Katouli, Tor Bark, Torgny Svenberg, Roland M??llby & Olle Ljungqvist. (2003) Orally Inoculated Escherichia coli Strains Colonize the Gut and Increase Bacterial Translocation After Stress in Rats. Shock 20:3, pages 251-256.
Crossref
Richard J. Farrell, Lorraine Kyne & Ciarán P. Kelly. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
823
844
.
I.R. Poxton, J. McCoubrey & G. Blair. (2001) The pathogenicity of Clostridium difficile. Clinical Microbiology and Infection 7:8, pages 421-427.
Crossref
Linda S Boeckner, Marilynn I Schnepf & Bryan C Tungland. 2001.
1
63
.
Daniel Allen Nadeau. (2008) Intestinal Warfare: The Role of Short‐Chain Fructooligosaccharides in Health and Disease. Nutrition in Clinical Care 3:5, pages 266-273.
Crossref
R. J. Farrell & J. T. LaMont. 2000. Clostridium difficile. Clostridium difficile
109
125
.
Jane Freeman & Mark H Wilcox. (1999) Antibiotics and. Microbes and Infection 1:5, pages 377-384.
Crossref
Ciarán P. KellyMDMDJ. Thomas LaMontMDMD. (1998)
Clostridium difficile
Infection
. Annual Review of Medicine 49:1, pages 375-390.
Crossref
Gerald W. Tannock. 1997. Gastrointestinal Microbiology. Gastrointestinal Microbiology
187
215
.
Gerald W. Tannock. 1997. Gastrointestinal Microbiology. Gastrointestinal Microbiology
434
465
.
Linda A. Toth & Clark M. Blatteis. 2011. Comprehensive Physiology. Comprehensive Physiology
1489
1519
.
Val H. Smith & Robert D. Holt. (1996) Resource competition and within-host disease dynamics. Trends in Ecology & Evolution 11:9, pages 386-389.
Crossref
Christine Roffe. (1996) Biotherapy for antibiotic-associated and other diarrhoeas. Journal of Infection 32:1, pages 1-10.
Crossref
Stanislava Stavric & Ervin T. Kornegay. 1995. Biotechnology in Animal Feeds and Animal Feeding. Biotechnology in Animal Feeds and Animal Feeding
205
231
.
Blair A. Jobe, Andrew Grasley, Karen E. Deveney, Clifford W. Deveney & Brett C. Sheppard. (1995) Clostridium difficile colitis: An increasing hospital-acquired illness. The American Journal of Surgery 169:5, pages 480-483.
Crossref
Ciaran P. Kelly, Charalabos Pothoulakis & J. Thomas LaMont. (1994) Clostridium difficile Colitis. New England Journal of Medicine 330:4, pages 257-262.
Crossref
Charalabos Pothoulakis, Ignazio Castagliuolo, Ciaran P. Kelly & J.Thomas LaMont. (1993) Clostridium difficile-associated diarrhea and colitis: pathogenesis and therapy. International Journal of Antimicrobial Agents 3:1, pages 17-32.
Crossref
Val H. Smith. (1993) Resource Competition between Host and Pathogen. BioScience 43:1, pages 21-30.
Crossref
Val H. Smith. 1993. Advances in Microbial Ecology. Advances in Microbial Ecology
1
37
.
Roy FullerDavid J. Hentges. 1992. Probiotics. Probiotics
87
110
.